The Clinical and Radiological Manifestations in Coronavirus Disease 2019 With Negative Nucleic Acid Results.
COVID-19
RT-PCR
SARS-CoV-2
chest CT
early diagnosis
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
25
02
2020
accepted:
21
06
2020
entrez:
25
7
2020
pubmed:
25
7
2020
medline:
25
7
2020
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) was a new emerging disease with high infectiousness. Its diagnosis primarily depended on real-time polymerase chain reaction (RT-PCR) results. This study investigated epidemiological, clinical, and radiological characteristics of COVID-19 with negative RT-PCR results before confirmation. Patients with COVID-19 were enrolled and divided into 2 groups: a negative group with negative RT-PCR results before confirmation and a positive group with positive results at the first detection. Epidemiological and clinical features were compared. Dynamic chest computerized tomography (CT) images of the negative group were evaluated. Ninety-nine laboratory-confirmed patients with COVID-19 including 8 patients (8%) with negative RT-PCR results were included. Patients from the negative group had similar epidemiological features: the average age (50.25 ± 13.27 years in the negative group and 53.70 ± 16.64 years in the positive group) and gender distribution (males made up 50% of the negative group and 62.6% of the positive group) were comparable. No significant differences were observed in clinical symptoms between the 2 groups. We found that fever was the most common symptom for both groups, followed by cough, expectoration, chest distress, fatigue, and gastroenterological symptoms. Moreover, ground-glass opacities and consolidations were the main manifestation in chest CT of patients with COVID-19 with or without confirmed RT-PCR results. Regardless of initial RT-PCR results, patients with COVID-19 had similar epidemiological, clinical, and chest CT features. Our study suggests value from early chest CT scans in COVID-19 screening and dynamic significance of radiology in disease monitoring should guide clinical decisions.
Sections du résumé
BACKGROUND
BACKGROUND
Coronavirus disease 2019 (COVID-19) was a new emerging disease with high infectiousness. Its diagnosis primarily depended on real-time polymerase chain reaction (RT-PCR) results. This study investigated epidemiological, clinical, and radiological characteristics of COVID-19 with negative RT-PCR results before confirmation.
METHODS
METHODS
Patients with COVID-19 were enrolled and divided into 2 groups: a negative group with negative RT-PCR results before confirmation and a positive group with positive results at the first detection. Epidemiological and clinical features were compared. Dynamic chest computerized tomography (CT) images of the negative group were evaluated.
RESULTS
RESULTS
Ninety-nine laboratory-confirmed patients with COVID-19 including 8 patients (8%) with negative RT-PCR results were included. Patients from the negative group had similar epidemiological features: the average age (50.25 ± 13.27 years in the negative group and 53.70 ± 16.64 years in the positive group) and gender distribution (males made up 50% of the negative group and 62.6% of the positive group) were comparable. No significant differences were observed in clinical symptoms between the 2 groups. We found that fever was the most common symptom for both groups, followed by cough, expectoration, chest distress, fatigue, and gastroenterological symptoms. Moreover, ground-glass opacities and consolidations were the main manifestation in chest CT of patients with COVID-19 with or without confirmed RT-PCR results.
CONCLUSIONS
CONCLUSIONS
Regardless of initial RT-PCR results, patients with COVID-19 had similar epidemiological, clinical, and chest CT features. Our study suggests value from early chest CT scans in COVID-19 screening and dynamic significance of radiology in disease monitoring should guide clinical decisions.
Identifiants
pubmed: 32704513
doi: 10.1093/ofid/ofaa252
pii: ofaa252
pmc: PMC7337757
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofaa252Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
Clin Infect Dis. 2014 Jul 15;59(2):160-5
pubmed: 24723278
Radiology. 2020 Apr;295(1):202-207
pubmed: 32017661
BMJ. 2020 Feb 19;368:m606
pubmed: 32075786
Thorax. 2004 Mar;59(3):252-6
pubmed: 14985565
JAMA. 2020 Feb 7;:
pubmed: 32031568
Crit Care. 2019 Oct 30;23(1):337
pubmed: 31665057
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Radiology. 2004 Mar;230(3):836-44
pubmed: 14990845
AJR Am J Roentgenol. 2014 Oct;203(4):782-7
pubmed: 24918624
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Emerg Infect Dis. 2003 Sep;9(9):1064-9
pubmed: 14519241
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535